InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

FATE THERAPEUTICS INC

FATE Clue Score25
United States Fiscal year ends December CIK 0001434316 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Kamal Adawi
3 Nov 2026
Chief Financial Officer
Sell
6,582
$2.05
$13.52K
Bahram Valamehr
4 Aug 2026
President and CEO
Sell
43,947
$2.46
$108.10K
Cindy Tahl
4 Aug 2026
See Remarks
Sell
38,800
$2.46
$95.41K
Bahram Valamehr
20 May 2026
President and CEO
Sell
28,946
$1.88
$54.48K
Cindy Tahl
20 May 2026
See Remarks
Sell
25,590
$1.88
$48.08K
Cindy Tahl
6 May 2026
See Remarks
Exercised, kept
44,444
$1.05
$46.67K
Cindy Tahl
6 May 2026
See Remarks
Exercised, kept
122,220
$1.32
$161.33K
William H Rastetter
5 May 2026
Director
Exercised, kept
25,000
$1.69
$42.25K
Robert S Epstein
5 May 2026
Director
Exercised, kept
25,000
$1.69
$42.25K
Bahram Valamehr
9 Jan 2026
President and CEO
Sell
5,190
$1.07
$5.56K
Cindy Tahl
9 Jan 2026
See Remarks
Sell
10,589
$1.06
$11.28K

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 18,631,912
History held since 7 Oct 2013